• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

报告一项群体药代动力学-药效学研究:从期刊的角度来看

Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective.

作者信息

Jamsen Kris M, McLeay Sarah C, Barras Michael A, Green Bruce

机构信息

Model Answers Pty Ltd, Suites 3-4, 333 Ann St, Brisbane, QLD, 4000, Australia,

出版信息

Clin Pharmacokinet. 2014 Feb;53(2):111-22. doi: 10.1007/s40262-013-0114-1.

DOI:10.1007/s40262-013-0114-1
PMID:24327237
Abstract

The key purpose of performing pharmacometric research is to aid optimization of drug dosing strategies. The statistical techniques required for this research are advanced, which can make interpretation of results difficult to convey to the target audience if they are unfamiliar with pharmacometric concepts. This article provides a basic guide for authors who wish to publish pharmacometric analyses in peer-reviewed journals. This guide is intended to enhance the readability, reproducibility and understanding of the work for a general readership, which may include clinicians, pharmacists and pharmacometricians. Presentation techniques and examples are offered, as well as a checklist of suggested contents for the manuscript.

摘要

进行药代动力学研究的关键目的是帮助优化给药策略。这项研究所需的统计技术很先进,如果目标受众不熟悉药代动力学概念,就难以向他们传达结果的解释。本文为希望在同行评审期刊上发表药代动力学分析的作者提供了基本指南。本指南旨在提高普通读者对该研究的可读性、可重复性和理解度,这些读者可能包括临床医生、药剂师和药代动力学家。文中提供了展示技巧和示例,以及手稿建议内容的清单。

相似文献

1
Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective.报告一项群体药代动力学-药效学研究:从期刊的角度来看
Clin Pharmacokinet. 2014 Feb;53(2):111-22. doi: 10.1007/s40262-013-0114-1.
2
How to write and publish scientific papers: scribing information for pharmacists.如何撰写和发表科学论文:为药剂师记录信息。
Am J Hosp Pharm. 1992 Oct;49(10):2477-84.
3
Population pharmacokinetics. A regulatory perspective.群体药代动力学。监管视角。
Clin Pharmacokinet. 1999 Jul;37(1):41-58. doi: 10.2165/00003088-199937010-00003.
4
Writing for publication in biomedical journals.撰写用于在生物医学期刊上发表的文章。
Prehosp Emerg Care. 2002 Apr-Jun;6(2 Suppl):S32-7. doi: 10.3109/10903120209102680.
5
Animal Pharmacokinetic/Pharmacodynamic Studies (APPS) Reporting Guidelines.动物药代动力学/药效学研究(APPS)报告指南。
Eur J Drug Metab Pharmacokinet. 2018 Oct;43(5):483-494. doi: 10.1007/s13318-018-0498-2.
6
Review article: reporting guidelines in the biomedical literature.综述文章:生物医学文献中的报告规范。
Can J Anaesth. 2013 Aug;60(8):813-21. doi: 10.1007/s12630-013-9973-z. Epub 2013 Jun 13.
7
Journal publication ethics and implications for life science researchers: a COPE perspective.期刊出版伦理及其对生命科学研究人员的影响:COPE视角
Emerg Top Life Sci. 2018 Dec 21;2(6):763-767. doi: 10.1042/ETLS20180164.
8
The factors considered by editors of plastic surgery journals in evaluating submitted manuscripts.整形外科学术期刊编辑在评估投稿稿件时所考虑的因素。
Aesthetic Plast Surg. 2008 Mar;32(2):353-8. doi: 10.1007/s00266-007-9079-5.
9
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
10
Manuscript Development and Publishing: A 5-Step Approach.稿件撰写与发表:五步走方法
Am J Med Sci. 2017 Feb;353(2):132-136. doi: 10.1016/j.amjms.2016.12.005. Epub 2016 Dec 9.

引用本文的文献

1
Tailoring oral targeted therapies dosage in lung cancer: A systematic review of pharmacokinetics studies on renal and hepatic impairment.肺癌口服靶向治疗药物剂量调整:关于肾和肝损伤的药代动力学研究的系统评价
PLoS One. 2025 Jul 29;20(7):e0324056. doi: 10.1371/journal.pone.0324056. eCollection 2025.
2
Significant Predictors of Azithromycin in Population Pharmacokinetic Analysis: A Systematic Review.阿奇霉素群体药代动力学分析中的显著预测因素:一项系统评价
Drug Des Devel Ther. 2025 Jul 4;19:5709-5725. doi: 10.2147/DDDT.S519597. eCollection 2025.
3
Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics.

本文引用的文献

1
A time to event tutorial for pharmacometricians.给药理计量学家的事件发生时间教程。
CPT Pharmacometrics Syst Pharmacol. 2013 May 15;2(5):e43. doi: 10.1038/psp.2013.18.
2
Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.群体建模、模拟及基于模型的药物研发基础概念——第2部分:药代动力学建模方法介绍
CPT Pharmacometrics Syst Pharmacol. 2013 Apr 17;2(4):e38. doi: 10.1038/psp.2013.14.
3
Best practices in population modeling should always be evolving.
阿奇霉素药代动力学的影响因素预测:群体药代动力学的系统评价
Ann Med. 2025 Dec;57(1):2496792. doi: 10.1080/07853890.2025.2496792. Epub 2025 May 15.
4
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients.米卡芬净群体药代动力学模型的评估:对危重症患者给药方案优化的意义
Pharmaceutics. 2024 Aug 29;16(9):1145. doi: 10.3390/pharmaceutics16091145.
5
Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin.卡泊芬净群体药代动力学模型库的开发与质量控制
Pharmaceutics. 2024 Jun 17;16(6):819. doi: 10.3390/pharmaceutics16060819.
6
Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.儿童患者甲氨蝶呤的群体药代动力学分析:系统评价。
Eur J Clin Pharmacol. 2024 Jul;80(7):965-982. doi: 10.1007/s00228-024-03665-x. Epub 2024 Mar 18.
7
Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease.非奈利酮:一种用于治疗慢性肾脏病的新型药物研发。
Curr Drug Discov Technol. 2024;21(6):e290124226291. doi: 10.2174/0115701638283354240103115420.
8
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban.亚洲人是否需要较低剂量的利伐沙班?利伐沙班群体药代动力学和药效学分析的系统评价。
Pharmaceutics. 2023 Feb 9;15(2):588. doi: 10.3390/pharmaceutics15020588.
9
Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models.影响他莫昔芬在乳腺癌患者中药代动力学的因素:群体药代动力学模型的系统评价
Biology (Basel). 2022 Dec 28;12(1):51. doi: 10.3390/biology12010051.
10
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review.溃疡性结肠炎和急性重症溃疡性结肠炎患者在英夫利昔单抗群体药代动力学模型中被忽视:一项综合综述的结果
Pharmaceutics. 2022 Sep 30;14(10):2095. doi: 10.3390/pharmaceutics14102095.
种群建模的最佳实践应该始终在不断发展。
CPT Pharmacometrics Syst Pharmacol. 2013 Jul 3;2(7):e52. doi: 10.1038/psp.2013.37.
4
Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance.建立群体建模最佳实践和指南:内部群体药代动力学分析指南的经验。
CPT Pharmacometrics Syst Pharmacol. 2013 Jul 3;2(7):e51. doi: 10.1038/psp.2013.26.
5
Basic concepts in population modeling, simulation, and model-based drug development.群体建模、模拟和基于模型的药物研发的基本概念。
CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1(9):e6. doi: 10.1038/psp.2012.4.
6
How to write a research paper.如何撰写一篇研究论文。
J Clin Epidemiol. 2013 Apr;66(4):353-4. doi: 10.1016/j.jclinepi.2013.01.007.
7
How to write a paper.如何撰写一篇论文。
ANZ J Surg. 2013 Jan;83(1-2):90-2. doi: 10.1111/ans.12036.
8
Ethical aspects and dilemmas of preparing, writing and publishing of the scientific papers in the biomedical journals.生物医学期刊中科学论文的撰写、发表所涉及的伦理问题与困境。
Acta Inform Med. 2012 Sep;20(3):141-8. doi: 10.5455/aim.2012.20.141-148.
9
Reporting guidelines: optimal use in preventive medicine and public health.报告规范:在预防医学和公共卫生中的最佳应用。
Am J Prev Med. 2012 Oct;43(4):e31-42. doi: 10.1016/j.amepre.2012.06.031.
10
Review article: A primer for clinical researchers in the emergency department: Part III: How to write a scientific paper.综述文章:急诊科临床研究人员入门:第三部分:如何撰写科学论文。
Emerg Med Australas. 2012 Aug;24(4):357-62. doi: 10.1111/j.1742-6723.2012.01569.x. Epub 2012 Apr 25.